Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Adolor Corporation
Public Company Edition: Merging with a special purpose acquisition corporation may be an attractive alternative to an initial public offering, but February’s vigorous IPO pace includes seven recent offerings that raised $480.8m in the US. Also, Cassava raised $200m and KalVista brought in $222.5m.
The Leeds, UK-based company is looking to the alternative route to the US stock market to fund its live biotherapeutics platform.
The device maker recalled more than 46,000 of its Medfusion 3500 and 4000 pumps because a software error can lead to over- or under-dosing.
The company sees KVD900 as potentially “ideal” for patients using on-demand and prophylactic therapy, given the existing need to carry backup on-demand medications.